JP2015536939A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536939A5 JP2015536939A5 JP2015540176A JP2015540176A JP2015536939A5 JP 2015536939 A5 JP2015536939 A5 JP 2015536939A5 JP 2015540176 A JP2015540176 A JP 2015540176A JP 2015540176 A JP2015540176 A JP 2015540176A JP 2015536939 A5 JP2015536939 A5 JP 2015536939A5
- Authority
- JP
- Japan
- Prior art keywords
- silica material
- porous silica
- material according
- food
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 32
- 239000000463 material Substances 0.000 claims 16
- 239000000377 silicon dioxide Substances 0.000 claims 16
- 239000011148 porous material Substances 0.000 claims 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 238000002560 therapeutic procedure Methods 0.000 claims 7
- 230000002265 prevention Effects 0.000 claims 5
- 210000000577 adipose tissue Anatomy 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 claims 4
- 229960001243 orlistat Drugs 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 208000032928 Dyslipidaemia Diseases 0.000 claims 3
- 206010020772 Hypertension Diseases 0.000 claims 3
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 claims 3
- 235000020824 obesity Nutrition 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 235000012041 food component Nutrition 0.000 claims 2
- 239000005417 food ingredient Substances 0.000 claims 2
- 150000003626 triacylglycerols Chemical class 0.000 claims 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 2
- 230000004580 weight loss Effects 0.000 claims 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261723019P | 2012-11-06 | 2012-11-06 | |
| US61/723,019 | 2012-11-06 | ||
| PCT/EP2013/073200 WO2014072363A1 (en) | 2012-11-06 | 2013-11-06 | A porous silica material for use as a pharmaceutical or dietary active ingredient |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018194145A Division JP6752858B2 (ja) | 2012-11-06 | 2018-10-15 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015536939A JP2015536939A (ja) | 2015-12-24 |
| JP2015536939A5 true JP2015536939A5 (https=) | 2016-12-22 |
| JP6421124B2 JP6421124B2 (ja) | 2018-11-07 |
Family
ID=49639855
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540176A Active JP6421124B2 (ja) | 2012-11-06 | 2013-11-06 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
| JP2018194145A Active JP6752858B2 (ja) | 2012-11-06 | 2018-10-15 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018194145A Active JP6752858B2 (ja) | 2012-11-06 | 2018-10-15 | 医薬有効成分又は食品有効成分としての使用のための多孔質シリカ材料 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10695294B2 (https=) |
| EP (2) | EP2916852B1 (https=) |
| JP (2) | JP6421124B2 (https=) |
| CN (2) | CN105188720A (https=) |
| AU (1) | AU2013343565B2 (https=) |
| BR (1) | BR112015010118A2 (https=) |
| CA (3) | CA3024640A1 (https=) |
| CY (1) | CY1124471T1 (https=) |
| DK (1) | DK2916852T3 (https=) |
| ES (1) | ES2878017T3 (https=) |
| HR (1) | HRP20211036T1 (https=) |
| HU (1) | HUE055017T2 (https=) |
| IL (1) | IL238538B (https=) |
| LT (1) | LT2916852T (https=) |
| PH (1) | PH12015501010B1 (https=) |
| PL (1) | PL2916852T3 (https=) |
| PT (1) | PT2916852T (https=) |
| SI (1) | SI2916852T1 (https=) |
| WO (1) | WO2014072363A1 (https=) |
| ZA (1) | ZA201502979B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013343565B2 (en) | 2012-11-06 | 2018-07-26 | Sigrid Therapeutics Ab | A porous silica material for use as a pharmaceutical or dietary active ingredient |
| EP2934495B1 (en) * | 2012-12-21 | 2017-07-19 | National Health Research Institutes | Mesoporous silica nanoparticles for oil absorption |
| US20200129444A1 (en) * | 2017-07-13 | 2020-04-30 | Carnegie Mellon University | Method of Increasing Epithelial Permeability Using Nanoparticles |
| CN111479555A (zh) * | 2017-12-13 | 2020-07-31 | L.I.瑞思有限公司 | 乳铁蛋白和二氧化硅的复合物、制备方法和口腔卫生组合物 |
| GB201803363D0 (en) | 2018-03-01 | 2018-04-18 | Sigrid Therapeutics Ab | New materials and uses thereof |
| DK3894857T3 (da) * | 2019-04-15 | 2022-11-07 | Nanologica Ab | Tomme porøse partikler til anvendelse ved behandling, forebyggelse og/eller udskydelse af degeneration af neurodegenerative sygdomme, neuroner og glia |
| CN110314151B (zh) * | 2019-08-02 | 2020-06-02 | 深圳国佳产业基金管理有限公司 | 医用介孔二氧化硅材料及其应用 |
| CN114729263A (zh) * | 2019-09-30 | 2022-07-08 | 零点火技术股份有限公司 | 隔热阻燃材料及其制造方法 |
| JP7578945B2 (ja) * | 2020-10-27 | 2024-11-07 | 信越化学工業株式会社 | イミダゾールシラン処理シリカからなる胆汁酸吸着剤 |
| CN114195885B (zh) * | 2022-01-12 | 2024-04-26 | 杭州隆基生物技术有限公司 | 一种单克隆抗体组合物提纯方法 |
| IL314498A (en) | 2022-02-04 | 2024-09-01 | Sigrid Therapeutics Ab | A preparation for oral care that includes porous silica particles |
| JP2025119063A (ja) | 2022-04-28 | 2025-08-14 | 日本たばこ産業株式会社 | 無機多孔質材料を含む口腔用組成物 |
| GB202212240D0 (en) | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New formulations and medical uses thereof |
| GB202212239D0 (en) | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New dietary supplements |
| CN116747321B (zh) * | 2023-06-14 | 2025-09-05 | 厦门君德医药科技有限公司 | 一种接枝改性的介孔二氧化硅及其制备方法和应用 |
| GB202312176D0 (en) | 2023-08-09 | 2023-09-20 | Sigrid Therapeutics Ab | New uses and methods |
| GB202312179D0 (en) | 2023-08-09 | 2023-09-20 | Sigrid Therapeutics Ab | New compositions and uses |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4185088A (en) | 1977-02-17 | 1980-01-22 | Merck & Co., Inc. | Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants |
| US4180566A (en) | 1978-05-15 | 1979-12-25 | W. R. Grace & Co. | Silica gel method of reducing blood lipid concentration |
| US4824672A (en) * | 1986-06-06 | 1989-04-25 | Hauser-Kuhrts, Inc. | Method and composition for reducing serum cholesterol |
| US5401466A (en) * | 1993-06-01 | 1995-03-28 | Miles Inc. | Device for the direct measurement of low density lipoprotein cholesterol |
| EP0778027A3 (de) | 1995-12-04 | 1998-04-01 | Helmut Univ.-Prof. Dr. Wachter | Verwendung von Kieselerde zur Herstellung von Arzneimitteln |
| EP0911078A1 (en) * | 1997-10-20 | 1999-04-28 | Hitachi Metals, Ltd. | Photocatalyst-supporting body and photocatalytic apparatus |
| AR019727A1 (es) * | 1998-06-30 | 2002-03-13 | Takeda Chemical Industries Ltd | Composicion farmaceutica |
| EP1202745A4 (en) * | 1999-08-16 | 2004-09-22 | Henceforth Hibernia Inc | THERAPEUTIC AND PROPHYLACTIC COMPOSITIONS CONTAINING CATALYTIC BIOMIMETIC SOLIDS AND METHODS OF PREPARING AND USING SAME |
| RU2241462C2 (ru) | 2000-07-28 | 2004-12-10 | Ф. Хоффманн-Ля Рош Аг | Новая фармацевтическая композиция |
| US7074440B2 (en) * | 2002-05-01 | 2006-07-11 | Rulin Xiu | Compositions and methods for body weight loss |
| JP2004345895A (ja) | 2003-05-21 | 2004-12-09 | Ajinomoto Co Inc | メソポーラスシリカ及びその製造方法 |
| JP2005289853A (ja) | 2004-03-31 | 2005-10-20 | Ajinomoto Co Inc | 経口リン酸吸着剤 |
| GB0515353D0 (en) | 2005-07-27 | 2005-08-31 | Psimedica Ltd | Food |
| KR100857411B1 (ko) | 2006-07-21 | 2008-09-08 | 한올제약주식회사 | 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법 |
| JP5670749B2 (ja) | 2008-02-11 | 2015-02-18 | ガルシア−ベネット, アルフォンソGARCIA−BENNETT, Alfonso | メソポーラス材料を製造する方法、それにより製造された材料及びメソポーラス材料の使用 |
| TW200936130A (en) * | 2008-02-26 | 2009-09-01 | Lundbeck & Co As H | Uses of indane compounds |
| EP2271358B1 (en) * | 2008-03-25 | 2018-11-21 | Amarantus Therapeutics, Inc. | use of mesencephalic astrocyte-derived neurotrophic factor for treating Parkinson's disease |
| JP2010065023A (ja) | 2008-08-14 | 2010-03-25 | Lion Corp | 脂溶性ビタミンおよび／または脂溶性色素含有粉体 |
| JP2012506904A (ja) | 2008-10-28 | 2012-03-22 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | 難水溶性成分のためのメソ多孔性材料賦形剤 |
| DE102009026686A1 (de) * | 2009-06-03 | 2010-12-23 | Airbus France | Anordnung zum Blitzschutz einer elektronischen Einheit |
| CN103003368B (zh) | 2010-03-17 | 2016-09-21 | 纳诺洛吉卡股份公司 | 增强的叶酸荧光材料、材料的多重荧光多孔组合物及其潜在的应用 |
| ES2768229T3 (es) | 2010-07-06 | 2020-06-22 | Nanologica Ab | Método mejorado para diferenciación de células madre in vivo mediante la administración de morfógenos con sílice mesoporosa y principios activos farmacéuticos correspondientes |
| GB201212866D0 (en) | 2012-07-20 | 2012-09-05 | Formac Pharmaceuticals Nv | Dry granulates of mesoporous silica powders |
| AU2013343565B2 (en) | 2012-11-06 | 2018-07-26 | Sigrid Therapeutics Ab | A porous silica material for use as a pharmaceutical or dietary active ingredient |
| CN113842362A (zh) | 2012-11-14 | 2021-12-28 | 格雷斯公司 | 含有生物活性材料与无序无机氧化物的组合物 |
| EP2934495B1 (en) | 2012-12-21 | 2017-07-19 | National Health Research Institutes | Mesoporous silica nanoparticles for oil absorption |
-
2013
- 2013-11-06 AU AU2013343565A patent/AU2013343565B2/en active Active
- 2013-11-06 BR BR112015010118A patent/BR112015010118A2/pt not_active Application Discontinuation
- 2013-11-06 US US14/440,784 patent/US10695294B2/en active Active
- 2013-11-06 WO PCT/EP2013/073200 patent/WO2014072363A1/en not_active Ceased
- 2013-11-06 JP JP2015540176A patent/JP6421124B2/ja active Active
- 2013-11-06 HR HRP20211036TT patent/HRP20211036T1/hr unknown
- 2013-11-06 SI SI201331885T patent/SI2916852T1/sl unknown
- 2013-11-06 HU HUE13795191A patent/HUE055017T2/hu unknown
- 2013-11-06 CA CA3024640A patent/CA3024640A1/en not_active Abandoned
- 2013-11-06 EP EP13795191.9A patent/EP2916852B1/en active Active
- 2013-11-06 CN CN201380069421.3A patent/CN105188720A/zh active Pending
- 2013-11-06 EP EP21162691.6A patent/EP3892285A3/en not_active Withdrawn
- 2013-11-06 ES ES13795191T patent/ES2878017T3/es active Active
- 2013-11-06 LT LTEP13795191.9T patent/LT2916852T/lt unknown
- 2013-11-06 PL PL13795191T patent/PL2916852T3/pl unknown
- 2013-11-06 PT PT137951919T patent/PT2916852T/pt unknown
- 2013-11-06 PH PH1/2015/501010A patent/PH12015501010B1/en unknown
- 2013-11-06 CA CA2890171A patent/CA2890171C/en active Active
- 2013-11-06 DK DK13795191.9T patent/DK2916852T3/da active
- 2013-11-06 CN CN202110214365.4A patent/CN113069467A/zh active Pending
-
2015
- 2015-04-30 IL IL238538A patent/IL238538B/en active IP Right Grant
- 2015-04-30 ZA ZA2015/02979A patent/ZA201502979B/en unknown
-
2018
- 2018-10-15 JP JP2018194145A patent/JP6752858B2/ja active Active
- 2018-11-15 CA CA3024460A patent/CA3024460A1/fr active Pending
-
2020
- 2020-06-26 US US16/913,533 patent/US12121612B2/en active Active
-
2021
- 2021-07-13 CY CY20211100628T patent/CY1124471T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015536939A5 (https=) | ||
| HRP20211036T1 (hr) | Porozni materijal silicij-dioksida za upotrebu kao farmaceutski ili dijetetski aktivni sastojak | |
| DK1632252T3 (da) | Hæmostatiske sammensætninger og anordninger | |
| JP2010104979A5 (https=) | ||
| JP2013516442A5 (https=) | ||
| PT2210588E (pt) | Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana | |
| JP2009280627A5 (https=) | ||
| JP2015515475A5 (https=) | ||
| TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
| SG11201804449WA (en) | 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders | |
| JP2015525099A5 (https=) | ||
| HK1198279A1 (en) | Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate | |
| GB201204696D0 (en) | Therapy | |
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| JP2014510590A5 (https=) | ||
| WO2011101734A3 (en) | Taste-masked powder for suspension compositions of methylprednisolone | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| WO2011093818A3 (en) | Pharmaceutical compositions comprising salmeterol and fluticasone | |
| JP2014500257A5 (https=) | ||
| WO2009133470A3 (en) | Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level | |
| WO2012147101A3 (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof | |
| JP2016523943A5 (https=) | ||
| HRP20221034T1 (hr) | Aklidinij za upotrebu u povećanju fizičke aktivnosti u dnevnom životu kod pacijenta koji pati od kronične opstruktivne bolesti pluća | |
| HK1209041A1 (en) | A method of weight reduction | |
| IL204957A (en) | Derivatives of 3 - (aminoalkoxyimino) - androstane and androsten |